SupplyManager℠  Become a Customer

  • #842097
  • 503
  • Pfizer #00005197105
Prevnar 13® Pneumonia Vaccine Children 6 Weeks Through 5 Years of Age and Adults 50 Years of Age and Older Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free Injection Prefilled Syringe 0.5 mL

Features
  • In children 6 weeks through 5 years of age, Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
  • In children Prevnar is also indicated for active immunization for the prevention of otitis media caused by Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F
  • No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, 7F, and 19A
  • More …
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #842097
Manufacturer #00005197105
BrandPrevnar 13®
ManufacturerPfizer
Alternate Manufacturer Number2021178
ApplicationPneumonia Vaccine
Container TypePrefilled Syringe
Dosage FormInjection
Generic Drug Code28232
Generic Drug NamePneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free
NDC Number00005-1971-05
Storage RequirementsRequires Refrigeration
TypeIntramuscular
UNSPSC Code51201615
UserChildren 6 Weeks Through 5 Years of Age and Adults 50 Years of Age and Older
Volume0.5 mL
Features
  • In children 6 weeks through 5 years of age, Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
  • In children Prevnar is also indicated for active immunization for the prevention of otitis media caused by Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F
  • No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, 7F, and 19A
  • In children 6 years through 17 years of age Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
  • In adults 50 and older, Prevnar 13 is indicated for the active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
  • The tip cap and rubber plunger of the prefilled syringe do not contain latex
  • Store Refrigerated at 2° to 8°C (36° to 46°F)